Opportunities
Search

Buyer: Police Fédérale | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-23

Buyer: Police Fédérale | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-23

Buyer: ΠΕΡΙΦΕΡΕΙΑ ΔΥΤΙΚΗΣ ΜΑΚΕΔΟΝΙΑΣ | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-23

Buyer: Stichting Regionaal Opleidingen Centrum Aventus | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-23

Buyer: Provincie Noord-Holland | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-23

Buyer: European Commission, DG EMPL - Employment, Social Affairs and Inclusion | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-23

Buyer: Valsts akciju sabiedrība "Latvijas dzelzceļš" | Notice type: pin-rtl | Procedure: open | Contract: services | Deadline: 2026-09-23

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD).Distinctive Features:• Applications must address at least one of the following focus areas: ○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here. ○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD.• Clinical research is allowed, however clinical trials and animal research are prohibited.• Preliminary data are required.• Community collaboration is required for research prospectively enrolling human subjects.• Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s).Distinctive Features:Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity.Studies utilizing animal models do not meet the intent of the mechanism and are not allowed.Preliminary data are required.Community collaboration is required for research prospectively enrolling human subjects.The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis.Distinctive Features:Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required.Community collaboration is required for studies prospectively enrolling human subjects.Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged.Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Expected Outcome:The Synergy action for Teaming Centres of Excellence (CoE) responds to the need to ensure the sustainability of CoE funded under the Teaming calls[1]. The establishment of CoE in Widening countries, supported by a significant investment in Horizon 2020 and Horizon Europe, has created new opportunities for scientific, societal, and economic impact. However, to fully capitalise on this investment and enhance the sustainability and international competitiveness of these CoE, it is essential to facilitate stronger collaboration and strategic joint initiatives among them.Proposals are expected to contribute to all the following outcomes:Stronger long-term collaboration among Teaming CoE through structured joint initiatives and clustering efforts to enhance mutual learning, resource sharing, and collective research and innovation capacity;Strategic transformation of R&I system...

Expected Outcome:Excellent capacities in research management are essential for institutions and national R&I systems to enhance their research excellence and capitalize on their R&I activities in a knowledge-based economy and society. The Research Management Facility aims at providing institutions in Widening countries that want to establish or upgrade their research management capacities with tailored support. The Research Management Facility also advises on an implementation strategy to introduce changes in the institutional set-up, in line with the ERA priorities. However, the action does not provide support for the implementation of the strategy.Strong research management ensures effective grant acquisition, resource allocation, compliance with funding regulations, and strategic planning. It supports high-quality research by streamlining administrative processes, facilitating interdi...

Expected Outcome:The Hop-on Facility allows for legal entities from Widening countries to join already funded Horizon Pillar II ‘main’ work programme and EIC Pathfinder collaborative R&I actions, subject to the agreement of the respective consortium and provided that legal entities from such countries are not yet participating as beneficiary, associated partner, or affiliated entity. The scheme aims to improve the inclusiveness of Horizon Europe. Selected consortia will be invited to submit a grant agreement amendment request of the eligible already funded action.Project results are expected to contribute to the following outcomes:At system level, mobilise excellence in the Widening countries, increase visibility of the beneficiaries from the widening countries, improve knowledge circulation, and boost their participation in specific thematic domains;At consortium level, open up establis...

Expected Impact:In the short term, the funding is expected to:Increase understanding and dissemination of challenges, risks and good practices in the priority areas identified under this call;Enhance communication, coordination and operational cooperation between authorities responsible for the prevention, detection and repression of corruption;Improve the availability and use of data, methodologies and tools for measuring corruption risks, trends and the impact of anti-corruption measures. Where applicable, proposals should demonstrate how they build on relevant previous or ongoing EU-funded projects and existing corruption measurement frameworks.In the long term, the funding is expected to:Improve the prevention, detection, investigation and prosecution of corruption across the EU;Contribute to the implementation of EU anti-corruption policy priorities, including recommendations addres...

Buyer: Stadt Bietigheim-Bissingen | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: Stadt Bietigheim-Bissingen | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: Rijksvastgoedbedrijf | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2026-09-24

Buyer: Stadt Bietigheim-Bissingen | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24

Buyer: Coöperatie Samen Innoveren/Inkopen/Ict voor Onderwijs Nederland UA | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-24

Buyer: Communauté Urbaine de Dunkerque | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Ville de Gannat | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Conseil Départemental des Bouches du Rhône | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Freistaat Bayern Vertreten durch die Akademie für Lehrerfortbildung und Personalführung (ALP) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-24

Buyer: Woonsprong bv | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-24